Patient Involvement Blog

Latest Tweets

News Archives

Latest News

  • New trial for blindness rewrites the genetic code

    Posted 20 March 2017
    Researchers have started a new gene therapy clinical trial to treat X-linked retinitis pigmentosa (XLRP), the most common cause of blindness in young people. Retinitis pigmentosa is currently untreatable and leads to a slow and irreversible loss of vision. On 16 March 2017, a 29-year-old British man became the first patient with X-linked retinitis pigmentosa ... Read more
  • Genetic sequencing offers same-day TB testing

    Posted 15 March 2017
    Researchers have for the first time shown that standard tuberculosis (TB) diagnostic tests can be replaced by a sub-24 hour genetic test applied to the TB bacteria in a patient’s sputum. It currently takes up to two months to obtain the full diagnostic information for a patient with TB, as the bacteria grow very slowly ... Read more
  • Hospital tablet computers cut nurse time by up to 30 per cent, study finds

    Posted 16 February 2017
    A project to replace bedside paper charts with tablet computers in Oxfordshire’s NHS hospitals reduced the typical time taken to input patients’ vital signs by up to 30%, a study has found. The System for Electronic Notification and Documentation (SEND) was developed by the University of Oxford for recording patient vital signs. A study of ... Read more
  • Public Health Minister Visits Oxford Cancer Hospital ahead of World Cancer Day

    Posted 4 February 2017
    Ahead of World Cancer Day on February 4, Public Health Minister Nicola Blackwood highlighted the importance of UK scientific research to beating cancer during a visit to the Churchill Hospital. The Public Health and Innovation Minister saw state-of-the-art clinical trials and facilities for new cancer treatments and patients, both supported by the NIHR Oxford Biomedical ... Read more
  • Oxfordshire research funding programme praised for impact on NHS

    Posted 3 February 2017
    A 10-year programme of research funding at Oxfordshire’s hospitals has had a positive impact on patient care, a new paper has reported. Interviews with clinical leaders on the work of the NIHR Oxford Biomedical Research Centre (BRC) found ‘numerous’ examples of positive impact on patient care. The interviews with 37 leaders also identified challenges resulting ... Read more
  • Industry partnership to deploy digital technology in NHS

    Posted 2 February 2017
    Drayson Technologies, Oxford University and Oxford University Hospitals (OUH) NHS Foundation Trust have signed three agreements to collaborate on the development, testing and future commercialisation of three clinically validated digital health products arising from BRC-funded research undertaken by engineers and doctors at Oxford University and OUH. The products are designed to provide significant improvements in ... Read more
  • Antibiotics, not dirty hospitals, the main cause of C. difficile epidemic

    Posted 24 January 2017
    Restricting the use of a common antibiotic was more important than a high profile “deep clean” of hospitals in massively reducing UK antibiotic resistant Clostridium difficile (C. diff) cases, a major new study has found. The study concluded that overuse of antibiotics like ciprofloxacin led to the outbreak of severe diarrhoea caused by C. difficile ... Read more
  • Second key step for eye robot trial

    Posted 28 December 2016
    A robot has been used to inject a drug into the back of the eye in a world first for the next phase of a landmark clinical trial at Oxford’s John Radcliffe Hospital. Prof Robert MacLaren used the remotely controlled robot to administer a tiny volume of blood dissolving agent tPA under the retina to ... Read more
  • Funding boost for genetics centre

    Posted 8 December 2016
    A major University of Oxford genetics research centre that supports Oxford BRC research is to share £118m of new funding. Global medical research funding charity Wellcome has announced funding for The Wellcome Centre for Human Genetics. The aim of the centre is to advance understanding of health and disease, and span fundamental and social sciences, ... Read more
  • Nanopore genetics breakthrough supported by Oxford BRC

    Posted 2 December 2016
    Oxford University’s Wellcome Trust Centre for Human Genetics (WTCHG) and the leading genome analytics company Genomics plc has announced the first sequencing and analysis of multiple human genomes using nanopore technology. The announcement, made on Thursday, December 1, at the Oxford Nanopore Community Meeting in New York City, marks a major breakthrough in sequencing technology ... Read more